Penn Pharmaceutical Services U.S. Inc, asubsidiary of UK-based Penn Pharmaceutical Services Ltd., has expanded its clinical trial supplies distribution capabilities with the opening of a 75,000-sq.-ft., temperature-controlled storage and distribution facility in South Wales, UK.
 
The new facility has 2,400 pallet locations, making it one of the EU's largest facilities with regulatory approval for the storage and distribution of investigational medicinal products (IMPs), according to the company. Paul Wituschek, U.S.-based director of business development, remarked, "The opening of our new storage and distribution facility in the UK means that we have increased our offering to non-EU pharma companies who are looking to break into the EU marketplace."

Mr. Wituschek added that Penn's storage and distribution services act as a 'portal' into Europe and beyond for U.S. companies, enabling them to import and distribute pharma products, including IMPs, for use in clinical trials programs.
 
Penn has global reach through an international sales force and strategic alliances for its services offered from its single site operation in South Wales. It is a Welsh company that provides a range of fully integrated and cost effective pharmaceutical development, clinical trial supply and custom manufacturing services to the international health care industry.

News from our sister sites